Dr Reddy's Labs gets EIR from USFDA for Srikakulam facility Ruchika Sharma6 Sept 2024 2:02 PM ISTHyderabad: Dr Reddy's Labs has announced that the Company has received the Establishment Inspection Report (EIR) from the US Food and Drug...
Strides Pharma Science arm gets USFDA nod for generic version of Theophylline Extended Release Tablets Ruchika Sharma6 Sept 2024 1:26 PM ISTBangalore: Strides Pharma Science Limited today announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited,...
USFDA approves Alembic Pharma Albendazole Tablets Ruchika Sharma6 Sept 2024 11:31 AM ISTVadodara: Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA)...
Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio Ruchika Sharma5 Sept 2024 2:30 PM ISTBoehringer Ingelheim acquires Saiba Animal Health, strengthens animal health RnD pipelineIngelheim: Boehringer Ingelheim has said it has acquired...
Lupin, Dr Reddy's Labs recall products in US over manufacturing issues: USFDA Ruchika Sharma5 Sept 2024 1:30 PM ISTNew Delhi: Pharma majors Lupin, Dr Reddy's Laboratories are recalling products in the US over manufacturing issues, according to a latest...
Upcoming medical device park in Himachal to provide employment to 10,000 persons: Harshwardhan Chauhan Ruchika Sharma5 Sept 2024 12:15 PM ISTShimla: The establishment of a Medical Device Park in Solan district is set to be a major employment generator in Himachal Pradesh. Spread across...
Shilpa Medicare announces submission of NDA for Oxylanthanum Carbonate to USFDA by Unicycive Therapeutics Ruchika Sharma5 Sept 2024 11:20 AM ISTKarnataka: Unicycive Therapeutics, Inc. has announced the submission of New Drug Application (NDA) to United States Food and Drug Application...
Lupin launches Mirabegron Extended-Release Tablets in US Ruchika Sharma4 Sept 2024 8:30 PM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Mirabegron Extended-Release Tablets, 50 mg, in the United States, after having...
Entod Pharma wins DCGI nod for PresVu eye drops to treat Presbyopia Ruchika Sharma4 Sept 2024 4:07 PM ISTNew Delhi: ENTOD Pharmaceuticals has received final approval from the Drug Controller General of India (DCGI) for its PresVu eye drops.. This...
NATCO Pharma Canada arm invests over Rs 67 crore in biotech company eGenesis Ruchika Sharma4 Sept 2024 1:02 PM ISTCanada: NATCO Pharma Limited has announced that its wholly-owned Canadian subsidiary, NATCO Pharma (Canada) Inc., has made an investment of US$...
Cipla Vice Chairman M K Hamied resigns after 47 years of service Ruchika Sharma4 Sept 2024 12:08 PM ISTMumbai: Cipla has announced the resignation of Mustafa Khwaja Hamied from the position of Vice Chairman and Non-Executive Director of the Company...
CDSCO Panel Approves Wockhardt's Protocol Amendment Proposal for antimicrobial drug Cefepime plus Zidebactam Dr. Divya Colin3 Sept 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved Wockhardt's...
